Related Articles
EXPRESSION OF PS2 AND CATHEPSIN-D IN BREAST-CANCER
pS2 protein detected by immunohistochemistry in archival primary breast cancer
Predictive significance of the proportion of ER-positive or PgR-positive tumor cells in response to neoadjuvant chemotherapy for operable HER2-negative breast cancer
Co-expressed type of ER and HER2 protein as a predictive factor in determining resistance to antiestrogen therapy in patients with ER-positive and HER2-positive breast cancer
Receptor status variation in primary breast cancer and subsequent accessible relapse